Cold Genesys' Series B Round

Cold Genesys raised a round of funding on August 05, 2015.

Cold Genesys is a clinical-stage immuno-oncology company focused on the development of oncolytic immunotherapies to combat cancer. In 2010, Cold Genesys acquired exclusive worldwide rights to develop …

Articles about Cold Genesys' Series B Round: